Different Medications to Induce Labor
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Misoprostol, Pitocin.
- Who it may be relevant to
- Registry conditions: Pregnancy, Labor. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial
Overview
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Detailed description
This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.
Interventions
- Drug Misoprostol
25 mcg vaginally every 6 hours - Drug Pitocin
3-6 mL intravenously every hour
Primary outcome measures
- Time from induction to delivery [Time frame: start of induction until delivery]
Secondary outcome measures (1)
- Delivery outcome [Time frame: at delivery]
Eligibility criteria
Inclusion criteria
\- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI > = 30
Exclusion criteria
\- Pregnant patient presenting to labor \& delivery for induction of labor with BMI < 30
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 2 centers
- Mount Sinai Hospital — New York
- Bronx Care Health System — The Bronx
Identifiers
NCT: NCT06259097 · STUDY-24-00118